Found: 5
Select item for more details and to access through your institution.
Treatment initiation rates of patients with positive anti-hepatitis C virus results in tertiary hospitals in Turkey.
- Published in:
- Journal of Infection in Developing Countries, 2024, v. 18, n. 3, p. 441, doi. 10.3855/jidc.17910
- By:
- Publication type:
- Article
Five‐year follow‐up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D.
- Published in:
- Liver International, 2024, v. 44, n. 1, p. 139, doi. 10.1111/liv.15745
- By:
- Publication type:
- Article
Quality‐of‐life scores improve after 96 weeks of PEG‐IFNa‐2a treatment of hepatitis D: An analysis of the HIDIT‐II trial.
- Published in:
- Liver International, 2023, v. 43, n. 8, p. 1663, doi. 10.1111/liv.15602
- By:
- Publication type:
- Article
Safety and Effectiveness of Tenofovir Alafenamide in the Turkish Population: A Systematic Review.
- Published in:
- Viral Hepatitis Journal / Viral Hepatit Dergisi, 2023, v. 29, n. 2, p. 43, doi. 10.4274/vhd.galenos.2023.2023-8-3
- By:
- Publication type:
- Article
Comparison of Tenofovir Alafenamide and Entecavir Therapy in Patients with Chronic Hepatitis B Initially Treated with Tenofovir Disoproxil: A Retrospective Observational Survey.
- Published in:
- Hepatitis Monthly, 2021, v. 21, n. 10, p. 1, doi. 10.5812/hepatmon.118721.
- By:
- Publication type:
- Article